The decisions that determine Phase 2 timing are made, or missed, in the first two quarters after the IND opens.
White Paper
IND Ready Is Not Phase 2 Ready
Related Resources
All Resources
infographic
Navigating the Regulatory Crossroads of Drug, Device, and Biologic
Read More
post
FDA PreCheck Program vs. Fast Track: Facility Readiness
Read More
post
QSR Is Gone. What Combination Product Sponsors Need to Know About the QMSR Switchover.
Read More
post
Another Nitrosamine Recall. Another Reminder That This Problem Isn’t Going Away.
Read More
Let's move from science to success.
Let’s Talk